{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:47:40Z","timestamp":1784382460088,"version":"3.55.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181508","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T17:38:08Z","timestamp":1501004288000},"page":"e0181508","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1"],"prefix":"10.1371","volume":"12","author":[{"given":"Arianna","family":"Marini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Aruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Micoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafina","family":"Guadagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Delany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam F.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7904-0184","authenticated-orcid":true,"given":"Oliver","family":"Koeberling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"ref1","unstructured":"WHO. WHO Surveillance Bulletins <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/csr\/disease\/meningococcal\/epidemiological\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/csr\/disease\/meningococcal\/epidemiological\/en\/<\/ext-link>. 2015."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","author":"RZ Jafri","year":"2013","journal-title":"Popul Health Metr"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","author":"KL Seib","year":"2011","journal-title":"Infection and immunity"},{"issue":"25\u201326","key":"ref4","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.vaccine.2009.01.075","article-title":"Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide","volume":"27","author":"LK McNeil","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"V Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"37","key":"ref6","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"HQ Jiang","year":"2010","journal-title":"Vaccine"},{"key":"ref7","article-title":"Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined","author":"M Biagini","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"MC Schneider","year":"2006","journal-title":"Journal of immunology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"G Madico","year":"2006","journal-title":"Journal of immunology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"LD Fletcher","year":"2004","journal-title":"Infection and immunity"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"JA Welsch","year":"2004","journal-title":"Journal of immunology"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","article-title":"Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen","volume":"197","author":"JA Welsch","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"DM Granoff","year":"2009","journal-title":"Infection and immunity"},{"issue":"3","key":"ref14","article-title":"Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older","volume":"138","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/00325481.2016.1203238","article-title":"Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba(R))","volume":"128","author":"A Gandhi","year":"2016","journal-title":"Postgraduate medicine"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"5","author":"R Pajon","year":"2011","journal-title":"PLoS neglected tropical diseases"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/IAI.00033-08","article-title":"Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines","volume":"76","author":"PT Beernink","year":"2008","journal-title":"Infection and immunity"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions","volume":"13","author":"C Schwechheimer","year":"2015","journal-title":"Nature reviews Microbiology"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.51.2.571-578.1986","article-title":"Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting","volume":"51","author":"E Wedege","year":"1986","journal-title":"Infection and immunity"},{"issue":"16","key":"ref20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"JW Tappero","year":"1999","journal-title":"Jama"},{"issue":"23","key":"ref21","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.vaccine.2014.03.068","article-title":"A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA)","volume":"32","author":"O Koeberling","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"e66536","DOI":"10.1371\/journal.pone.0066536","article-title":"Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa","volume":"8","author":"R Pajon","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"e1002981","DOI":"10.1371\/journal.ppat.1002981","article-title":"Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules","volume":"8","author":"S Johnson","year":"2012","journal-title":"PLoS pathogens"},{"key":"ref24","unstructured":"Structure of a Complex Between Ccps 6 and 7 of Human Complement Factor H and Neisseria Meningitidis Fhbp Variant 1 E283ae304a Mutant. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/Structure\/mmdb\/mmdbsrv.cgi?uid=104765\" xlink:type=\"simple\">http:\/\/www.ncbi.nlm.nih.gov\/Structure\/mmdb\/mmdbsrv.cgi?uid=104765<\/ext-link>."},{"key":"ref25","unstructured":"Neisseria Sequence Typing Home Page. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/pubmlst.org\/neisseria\/\" xlink:type=\"simple\">http:\/\/pubmlst.org\/neisseria\/<\/ext-link>."},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination","volume":"186","author":"PT Beernink","year":"2011","journal-title":"Journal of immunology"},{"key":"ref27","unstructured":"Delany I, Guadagnuolo S, inventors Promoters for increased protein expression in meningococcus patent CA2861946 A1. 2013 08 August 2013."},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12033-014-9804-7","article-title":"Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA)","volume":"57","author":"O Rossi","year":"2015","journal-title":"Mol Biotechnol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/IAI.03079-14","article-title":"Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium","volume":"83","author":"S Rondini","year":"2015","journal-title":"Infection and immunity"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.12688\/f1000research.3881.1","article-title":"Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009","volume":"3","author":"E Ispasanie","year":"2014","journal-title":"F1000Res"},{"key":"ref31","article-title":"Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents","author":"T Vesikari","year":"2015","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"issue":"39","key":"ref32","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1016\/j.vaccine.2015.06.103","article-title":"Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study","volume":"33","author":"KP Perrett","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.vaccine.2015.01.057","article-title":"A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice","volume":"33","author":"R Pajon","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"PB Keiser","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2010.11.064","article-title":"Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1","volume":"29","author":"B Brunelli","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jit239","article-title":"Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines","volume":"208","author":"M Konar","year":"2013","journal-title":"The Journal of infectious diseases"},{"issue":"29","key":"ref37","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.02.021","article-title":"Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis","volume":"23","author":"G Norheim","year":"2005","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"ref38","doi-asserted-by":"crossref","first-page":"B42","DOI":"10.1016\/j.vaccine.2009.05.001","article-title":"Meningococcal protein antigens and vaccines","volume":"27","author":"IM Feavers","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.vaccine.2013.12.070","article-title":"Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens","volume":"32","author":"JN Williams","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jinf.2015.05.006","article-title":"A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial","volume":"71","author":"L Marsay","year":"2015","journal-title":"The Journal of infection"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/IAI.63.9.3531-3536.1995","article-title":"Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine","volume":"63","author":"A Aase","year":"1995","journal-title":"Infection and immunity"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac","volume":"74","author":"J Findlow","year":"2006","journal-title":"Infection and immunity"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/CDLI.7.5.764-768.2000","article-title":"Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines","volume":"7","author":"DJ Sikkema","year":"2000","journal-title":"Clinical and diagnostic laboratory immunology"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.11.10","article-title":"Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines","volume":"10","author":"H Sanders","year":"2011","journal-title":"Expert review of vaccines"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/157016211798998772","article-title":"Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1","volume":"9","author":"MR Aghasadeghi","year":"2011","journal-title":"Current HIV research"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jsb.2013.12.006","article-title":"Crystallographic analysis of Neisseria meningitidis PorB extracellular loops potentially implicated in TLR2 recognition","volume":"185","author":"C Kattner","year":"2014","journal-title":"Journal of structural biology"},{"issue":"22","key":"ref47","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1016\/j.vaccine.2007.03.029","article-title":"TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A","volume":"25","author":"S Zughaier","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","article-title":"Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870","volume":"192","author":"VC Hou","year":"2005","journal-title":"The Journal of infectious diseases"},{"issue":"7240","key":"ref49","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"MC Schneider","year":"2009","journal-title":"Nature"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T10:09:17Z","timestamp":1602583757000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181508"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181508","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]}}}